The initial success of Viagra undeniably revolutionized the pharmaceutical landscape, but betting in companies heavily reliant on unbranded versions presents a uncertain picture. Despite early profits were significant, the cessation of patents and the rise of discounted alternatives have eroded sales. Thus, a thorough analysis of present financial